Your search returned 392 results.

Results
	381.	Copy number gain of MYCN gene is a recurrent genetic aberration and favorable prognostic factor in Chinese pediatric neuroblastoma patients. [electronic resource] by Wang, Miao Zhou, Chunju Cai, Rongqin Li, Yong Gong, Liping Producer: 20130627 In: Diagnostic pathology vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	382.	Diagnostic utility of cyclin D1 in the diagnosis of small round blue cell tumors in children and adolescents. [electronic resource] by Magro, Gaetano Salvatorelli, Lucia Alaggio, Rita D'Agata, Velia Nicoletti, Ferdinando Di Cataldo, Andrea Parenti, Rosalba Producer: 20170828 In: Human pathology vol. 60 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	383.	Disaloganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastoma. [electronic resource] by Kramer, K Gerald, W L Kushner, B H Larson, S M Hameed, M Cheung, N K Producer: 20010816 In: Medical and pediatric oncology vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	384.	Outcome prediction and risk assessment by quantitative pyrosequencing methylation analysis of the SFN gene in advanced stage, high-risk, neuroblastic tumor patients. [electronic resource] by Banelli, Barbara Bonassi, Stefano Casciano, Ida Mazzocco, Katia Di Vinci, Angela Scaruffi, Paola Brigati, Claudio Allemanni, Giorgio Borzì, Luana Tonini, Gian Paolo Romani, Massimo Producer: 20100119 In: International journal of cancer vol. 126 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	385.	In-111 pentetreotide scintigraphy in patients with neuroblastoma. Comparison with I-131 MIBG, N-Myc oncogene amplification, and patient outcome. [electronic resource] by Shalaby-Rana, E Majd, M Andrich, M P Movassaghi, N Producer: 19970717 In: Clinical nuclear medicine vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	386.	Image-defined risk factor assessment of neurogenic tumors after neoadjuvant chemotherapy is useful for predicting intra-operative risk factors and the completeness of resection. [electronic resource] by Irtan, Sabine Brisse, Hervé J Minard-Colin, Véronique Schleiermacher, Gudrun Galmiche-Rolland, Louise Le Cossec, Chloé Elie, Caroline Canale, Sandra Michon, Jean Valteau-Couanet, Dominique Sarnacki, Sabine Producer: 20151013 In: Pediatric blood & cancer vol. 62 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	387.	Evidence of chromaffin oxygen sensing in neuroblastoma. [electronic resource] by Hedborg, F Franklin, G Norrman, J Grimelius, L Wassberg, E Hero, B Schilling, F Berthold, F Harms, D Sandstedt, B Producer: 20010816 In: Medical and pediatric oncology vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	388.	Irinotecan-temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial. [electronic resource] by Mody, Rajen Naranjo, Arlene Van Ryn, Collin Yu, Alice L London, Wendy B Shulkin, Barry L Parisi, Marguerite T Servaes, Sabah-E-Noor Diccianni, Mitchell B Sondel, Paul M Bender, Julia G Maris, John M Park, Julie R Bagatell, Rochelle Producer: 20170911 In: The Lancet. Oncology vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	389.	Results of a prospective clinical trial JN-L-10 using image-defined risk factors to inform surgical decisions for children with low-risk neuroblastoma disease: A report from the Japan Children's Cancer Group Neuroblastoma Committee. [electronic resource] by Iehara, Tomoko Yoneda, Akihiro Yokota, Isao Takahashi, Hideto Teramukai, Satoshi Kamijyo, Takehiko Nakazawa, Atsuko Takimoto, Tetsuya Kikuta, Atsushi Yagyu, Shigeki Ikeda, Hitoshi Nakagawara, Akira Tajiri, Tatsuro Producer: 20200225 In: Pediatric blood & cancer vol. 66 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	390.	Immunohistochemical expression of CD44s in human neuroblastic tumors: Moroccan experience and highlights on current data. [electronic resource] by Tabyaoui, Imane Tahiri-Jouti, Nadia Serhier, Zineb Bennani-Othmani, Mohamed Sibai, Hicham Itri, Mohamed Benchekroun, Said Zamiati, Soumaya Producer: 20130627 In: Diagnostic pathology vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	391.	Survivin inhibits apoptosis induced by TRAIL, and the ratio between survivin and TRAIL receptors is predictive of recurrent disease in neuroblastoma. [electronic resource] by Azuhata, Takeo Scott, David Griffith, Thomas S Miller, Michal Sandler, Anthony D Producer: 20060919 In: Journal of pediatric surgery vol. 41 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	392.	High expression of the novel endothelin-converting enzyme genes, Nbla03145/ECEL1alpha and beta, is associated with favorable prognosis in human neuroblastomas. [electronic resource] by Kawamoto, T Ohira, M Hamano, S Hori, T Nakagawara, A Producer: 20031117 In: International journal of oncology vol. 22 Availability: No items available. Save to lists Add to cart (remove)

First
Previous
11
12
13
14
15
16
17
18
19
20